Tadashi Manabe
4PUBLICATIONS
80CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 07, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies.Tadashi Manabe, Hannah C Bergo, Qingtian Li
|Nov 24, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies.Tadashi Manabe, Hannah C Bergo, Qingtian Li
|Dec 04, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.Deborah R Caswell, Philippe Gui, Manasi K Mayekar
|Aug 22, 2022
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.Qingbo S Wang, Ryuya Edahiro, Ho Namkoong
Pageof 1
Frequent Collaborators
3 joint publications
Trever G Bivona
3 joint publications
Wei Wu
2 joint publications
Catherine Lee
2 joint publications
Joel W Neal
2 joint publications
Nicole Zhang
2 joint publications
Paul Severson
2 joint publications
Shumei Kato
2 joint publications
Kathryn Grandinetti
1 joint publications
Kotoe Katayama
1 joint publications
Kenichi Yamamoto
